Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03804710Completed
Randomised, single-blind trial (2 arms), sponsored by GSK. Primary endpoint: Change From Baseline in Trans-epidermal Water Loss at Day 29. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03804710.